Healthcare Services

Osteoarthritis Therapeutics Market Forecast Assessing Growth Potential And Industry Direction

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Size Of The Osteoarthritis Therapeutics Market In 2026 And How Much Will It Reach By 2030?

The osteoarthritis therapeutics market has observed significant growth over recent years. Its valuation is anticipated to climb from $8.87 billion in 2025 to $9.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.6%. This historical expansion can be attributed to an array of factors, including the increasing occurrence of osteoarthritis, the advancing age of the global population, the widespread use of NSAIDs and analgesics, the broadening availability of orthopedic care services, and the presence of well-established pain management therapies.

The osteoarthritis therapeutics market size is set for significant expansion in the coming years. It is forecast to grow to $13.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.2%. This growth during the forecast period stems from the increasing development of dmoads, rising demand for minimally invasive therapies, the expansion of biologic and cell-based treatments, a growing focus on personalized osteoarthritis care, and increased investment in joint disease research. Key trends in the forecast period encompass the increasing adoption of disease-modifying osteoarthritis therapies, rising use of regenerative medicine approaches, a growing focus on non-opioid pain management, the expansion of injectable and intra-articular treatments, and an enhanced emphasis on early disease intervention.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19634&type=smp

Which Significant Factors Are Encouraging Growth In The Osteoarthritis Therapeutics Market?

The osteoarthritis therapeutics market is projected to experience growth driven by an uptick in sports injuries. A sports injury refers to any form of damage or harm incurred during athletic or sporting endeavors. These injuries vary in severity from minor to serious and can affect multiple areas of the body. The escalation in sports injuries largely stems from increased involvement in sports activities, coupled with their rising intensity and competitive nature. Osteoarthritis therapeutics are utilized for sports injuries to alleviate pain and inflammation and to improve joint function for athletes grappling with joint degeneration. For instance, in July 2025, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that in Australia, during 2023–24, approximately 62,100 sports injuries necessitated hospital admission. Furthermore, males accounted for 70% of all hospitalizations (equating to 43,800 cases), whereas females comprised nearly 30% (or 18,300 cases). Thus, the increasing prevalence of sports injuries is propelling the expansion of the osteoarthritis therapeutics market.

Which Segment Divisions Form The Structure Of The Osteoarthritis Therapeutics Market?

The osteoarthritis therapeutics market covered in this report is segmented –

1) By Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids

2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs

5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses

Subsegments:

1) By Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products

2) By Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors

3) By Analgesics: Non-Opioid Analgesics, Topical Analgesics

4) By Corticosteroids: Injectable Corticosteroids, Intra-Articular Corticosteroids

Which Trends Are Expected To Shape The Osteoarthritis Therapeutics Market?

Companies operating in the osteoarthritis market are strategically collaborating to improve technology integration and broaden their market reach. A strategic partnership typically denotes a cooperative relationship between multiple organizations where they combine their resources, specialized knowledge, and efforts to achieve mutual goals. For example, in July 2024, LG Chem, a pharmaceutical company based in South Korea, initiated its entry into the Chinese market by forming a partnership with Yifan Pharmaceutical Co., Ltd., a pharmaceutical research and production company located in China. This collaboration aimed to launch Synovian injection for osteoarthritis, designed to provide therapeutic effects similar to conventional multi-injection formulations but through a single administration. Synovian’s notable attributes include its high molecular weight (10 million Dalton) hyaluronic acid, which enhances viscoelasticity and joint function, and its demonstrated capacity to significantly reduce knee pain, as evidenced by clinical phase 3 trial results. This development establishes Synovian as an effective alternative for patients seeking convenient alleviation of osteoarthritis symptoms.

Who Are The Key Market Participants In The Osteoarthritis Therapeutics Market?

Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Galapagos NV, Regeneron Pharmaceuticals Inc., Samumed LLC, Kolon Life Science Inc., Horizon Therapeutics plc

Access The Complete Osteoarthritis Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-therapeutics-global-market-report

Which Geographic Region Represents The Largest Osteoarthritis Therapeutics Market Share?

North America was the largest region in the osteoarthritis therapeutics market in 2025. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Osteoarthritis Therapeutics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=19634&type=smp

Browse Through More Reports Similar to the Global Osteoarthritis Therapeutics Market 2026, By The Business Research Company

Axial Spondyloarthritis Axspa Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/axial-spondyloarthritis-axspa-global-market-report

Gouty Arthritis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Osteoporosis Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795